Citations

Mayo Clinic

Showing 10 of 108551 citations.

SP13. Reviving The Potential Of Muscle-Nerve-Muscle Neurotization For Facial Reanimation
Millesi, Elena , Wang, Huan , Gibreel, Waleed , Mardini, Samir

Plastic and Reconstructive Surgery - Global Open | April 19, 2024 | Volume: 12 | Issue: S4 | Pages: 88-89

10.1097/01.gox.0001015616.20084.61 Get It

SP49. Outcomes Of Myoelectric Prosthetic Fitting On Activity Performance In Patients With Traumatic Brachial Plexus Injuries (BPI) After Elective Amputation
Saffari, Tiam M. , Nelson, Andrew W. , Samson, Brandon, Smithers, Clayton, Nelson, Andrew, Pulos, Nicholas , Shin, Alexander Y.

Plastic and Reconstructive Surgery - Global Open | April 19, 2024 | Volume: 12 | Issue: S4 | Pages: 111-112

10.1097/01.gox.0001015760.24131.9f Get It

SP30. A Comprehensive Analysis Of Long-term Facial Reanimation In A Face Transplant Recipient
Millesi, Elena , Gibreel, Waleed , Mardini, Samir

Plastic and Reconstructive Surgery - Global Open | April 19, 2024 | Volume: 12 | Issue: S4 | Pages: 99-100

10.1097/01.gox.0001015684.38151.a3 Get It

96. Cost Effectiveness Of Incisional Negative Pressure Wound Therapy In Penile Inversion Vaginoplasty
Sanchez, Maria V. Rios, Figueroa, Nicole Sanchez, Martinez‐Jorge, Jorys, Fahradyan, Vahe

Plastic and Reconstructive Surgery - Global Open | April 19, 2024 | Volume: 12 | Issue: S4 | Pages: 63-64

10.1097/01.gox.0001015472.19190.47 Get It

SP53. Comparing Collagenase And Tissue Subcision For Cellulite Treatment Of The Buttock And Thigh Regions: A Systematic Review And Meta-analysis
Raška, Otakar , Galinaud, Cécilia , Tarista, IIulianna C., Schuster, Kirsten A. , Ho, Olivia A. , TerKonda, Sarvam P. , Lin, Samuel J. , Foppiani, Jose , Stearns, Stephen, Alvarez, Angelica Hernandez , Lee, Bernard T.

Plastic and Reconstructive Surgery - Global Open | April 19, 2024 | Volume: 12 | Issue: S4 | Pages: 114-114

10.1097/01.gox.0001015776.61681.06 Get It

88. Brachial Plexopathy And Breast Cancer-related Lymphedema: Insights From A Retrospective Cohort Study
Eldaly, Abdullah S. , Maita, Karla C. , Velasquez, Gioacchino De Sario, Ho, Olivia A. , Borna, Sahar , Torres‐Guzman, Ricardo A. , Ávila, Francisco R. , Garcia, John P. , Forte, Antonio J.

Plastic and Reconstructive Surgery - Global Open | April 19, 2024 | Volume: 12 | Issue: S4 | Pages: 58-58

10.1097/01.gox.0001015440.86302.19 Get It

53. Accuracy Of Preoperative Imaging In Assessing The Involvement Of The Deep Periosteal Margin In Dermatofibrosarcoma Protuberans Of The Scalp: The Mayo Clinic Experience
Cherukuri, Sai , Zheng, Eugene, Brewer, Jerry D., Bite, Uldis, Guérin, J. , Mardini, Samir , Gibreel, Waleed

Plastic and Reconstructive Surgery - Global Open | April 19, 2024 | Volume: 12 | Issue: S4 | Pages: 37-38

10.1097/01.gox.0001015304.65440.42 Get It

Cell‐based tissue engineered flexor tendon allograft: A canine in vivo study
Lin, Subin, Reisdorf, Ramona L., Lu, Chun Kuan, An, Kai‐Nan, Moran, Steven L. , Amadio, Peter C. , Zhao, Chunfeng , Reisdorf, Ramona, Wang, Zhanwen , Amadio, Peter C , Zhao, Chunfeng , An, Kai‐Nan

Journal of Orthopaedic Research | April 19, 2024 | Volume: 42 | Issue: 9 | Pages: 1923-1932

10.1002/jor.25854 | PMID 38639414 Get It

AbstractThis study aimed to compare the clinically established autologous extrasynovial tendon graft to a newly developed tissue‐engineered allograft (Eng‐allograft) in terms of functional outcomes following flexor tendon reconstruction in a canine model. The second and fifth flexor digitorum profundus (FDP) tendons from 16 dogs were transected and repaired in Zone II. After 6 weeks of cage activity, the repaired tendons were intentionally ruptured, creating a clinically relevant model for reconstruction. The re‐ruptured FDP tendons were then reconstructed using either the clinically standard autologous extrasynovial tendon graft or the Eng‐allograft, which had been revitalized with autologous bone marrow‐derived mesenchymal stem cells (BMSCs) and synovialized using carbodiimide derivatized synovial fluid (cd‐SYN). Following 12 weeks of postoperative rehabilitation, the functional outcomes of the surgical digits were evaluated. The Eng‐allograft group exhibited improved digital function, including lower digit work of flexion and reduced adhesion status, while maintaining similar tendon gliding resistance compared to the autograft group. However, the failure load of both the distal and proximal host/graft conjunctions in the Eng‐allograft group was significantly lower than that of the autograft group with higher graft rupture at the host−graft junction. In conclusion, the decellularized allogenic intrasynovial tendon, when revitalized BMSCs and synovialized with cd‐SYN, demonstrates positive effects on digital function improvement and adhesion reduction. However, the healing at both proximal and distal graft/host junctions is far lower than the autograft. Further research is needed to enhance the healing capacity of allograft conjunctions, aiming to achieve a comparable level of healing seen with autografts.
Trends and Disparities in Treatment and Control of Atherosclerotic Cardiovascular Disease in US Adults, 1999 to 2018
Li, Jingen , Zhang, J , Somers, Virend K. , Covassin, Naima , Zhang, Lijing , Xu, Hao , Zhang, Jie , Somers, Virend K. , Li, Jingen

Journal of the American Heart Association | April 19, 2024 | Volume: 13 | Issue: 9 | Pages: No page available

10.1161/jaha.123.032527 | PMID 38639366 Get It

Background Although cardiovascular mortality continued declining from 2000 to 2019, the rate of this decrease decelerated. We aimed to assess the trends and disparities in risk factor control and treatment among US adults with atherosclerotic cardiovascular disease to find potential causes of the deceleration. Methods and Results A total of 55 ,021 participants, aged ≥20 years, from the 1999 to 2018 National Health and Nutrition Examination Survey were included, of which 5717 were with atherosclerotic cardiovascular disease. Risk factor control was defined as hemoglobin A1c <7%, blood pressure <140/90 mm Hg, and non–high‐density lipoprotein cholesterol <100 mg/dL. The prevalence of atherosclerotic cardiovascular disease oscillated between 7.3% and 8.9% from 1999 to 2018. A significant increasing trend was observed in the prevalence of diabetes, obesity, heavy alcohol consumption, and self‐reported hypertension within the population with atherosclerotic cardiovascular disease ( P trend ≤0.001). Non–high‐density lipoprotein cholesterol <100 mg/dL increased from 7.1% in 1999 to 2002 to 15.7% in 2003 to 2006, before plateauing. Blood pressure control (<140/90 mm Hg) increased until 2011 to 2014, but declined to 70.1% in 2015 to 2018 ( P trend <0.001, P joinpoint =0.14). Similarly, the proportion of participants achieving hemoglobin A1c control began to decrease after 2006 ( P joinpoint =0.05, P trend =0.001). The percentage of participants achieving all 3 targets increased significantly from 4.5% to 18.6% across 1999 to 2018 ( P trend =0.02), but the increasing trend decelerated after 2005 to 2006 ( P joinpoint <0.001). Striking disparities in risk factor control and medication use persisted between sexes, and between different racial and ethnic populations. Conclusions Worsened control of glycemia, blood pressure, obesity, and alcohol consumption, leveled lipid control, and persistent socioeconomic disparities may be contributing factors to the observed deceleration in decreasing cardiovascular mortality trends.
Patients With Coronary Microvascular Dysfunction Have Less Circulating α‐Klotho
Akhiyat, Nadia , Ӧzcan, Ilke , Gulati, Rajiv , Kirkland, James L. , Lewis, Bradley R., Lerman, Lilach O. , Lerman, Amir , Ozcan, Ilke , Prasad, Abhiram , Tchkonia, Tamara, Kirkland, James L , Lewis, Bradley R , Lerman, Lilach O , Lerman, Amir , Prasad, Abhiram , Tchkonia, Tamar

Journal of the American Heart Association | April 19, 2024 | Volume: 13 | Issue: 9 | Pages: No page available

10.1161/jaha.123.031972 | PMID 38639380 Get It

Background Coronary microvascular dysfunction (CMD) represents an early functional characteristic of coronary vascular aging. Klotho (α‐klotho) is a circulating protein inversely linked to physiological aging. We examined low klotho as a potential marker for vascular aging in patients with CMD and no coronary artery disease. Methods and Results Patients undergoing nonurgent angiogram for chest pain who had no coronary artery disease underwent invasive coronary microvascular and endothelial function testing. CMD was defined by ≤50% increase in coronary blood flow (percentage change in coronary blood flow) in response to intracoronary acetylcholine or coronary flow reserve ≤2. Fresh arterial whole blood was used to analyze circulating endothelial progenitor cells with flow cytometry. Stored arterial plasma was used for klotho analysis by ELISA. Participants with CMD (n=62) were compared with those without CMD (n=36). Those with CMD were age 55±10 years (versus 51±11 years; P =0.07) and 73% women (versus 81%; P =0.38). Traditional risk factors for coronary artery disease were similar between groups. Patients with CMD had less klotho (0.88±1.50 versus 1.75±2.38 ng/mL; P =0.03), and the odds of low klotho in CMD were significant in a logistic regression model after adjusting for traditional cardiovascular risk factors (odds ratio [OR], 0.80 [95% CI, 0.636–0.996]; P =0.05). Higher klotho was associated with higher numbers of endothelial progenitor cells with vascular regenerative potential (CD34 + and CD34 + CD133 + KDR + ). Among a subgroup of patients with atherosclerotic cardiovascular disease risk <5% (n=58), CMD remained associated with lower klotho (OR, 0.80 [95% CI, 0.636–0.996]; P =0.047). Conclusions Klotho may be a biomarker for CMD and may be a therapeutic target for groups of patients without significant traditional cardiovascular risk.